1-8 of 8
Tomohide Tamura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors

Kazuhiko Yamada, Noboru Yamamoto, Yasuhide Yamada, Hiroshi Nokihara, Yutaka Fujiwara, Taizo Hirata, Fumiaki Koizumi, Kazuto Nishio, Noriyuki Koyama, Tomohide Tamura
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2528–2537.
https://doi.org/10.1158/1078-0432.CCR-10-2638
Published: 14 April 2011
View article titled, Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Prospective Study of the Accuracy of EGFR Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non–Small Cell Lung Cancer

Tomoya Fukui, Yuichiro Ohe, Koji Tsuta, Koh Furuta, Hiromi Sakamoto, Toshimi Takano, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine, Hideo Kunitoh, Hisao Asamura, Takaaki Tsuchida, Masahiro Kaneko, Masahiko Kusumoto, Seiichiro Yamamoto, Teruhiko Yoshida, Tomohide Tamura
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4751–4757.
https://doi.org/10.1158/1078-0432.CCR-07-5207
Published: 01 August 2008
View article titled, Prospective Study of the Accuracy of <em>EGFR</em> Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non–Small Cell Lung Cancer
Open the PDF for Prospective Study of the Accuracy of <em>EGFR</em> Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non–Small Cell Lung Cancer in another window
Journal Articles

Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer

Yuichiro Ohe, Yukito Ichinose, Kazuhiko Nakagawa, Tomohide Tamura, Kaoru Kubota, Nobuyuki Yamamoto, Susumu Adachi, Yoshihiro Nambu, Toshio Fujimoto, Yutaka Nishiwaki, Nagahiro Saijo, Masahiro Fukuoka
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4206–4212.
https://doi.org/10.1158/1078-0432.CCR-07-5143
Published: 01 July 2008
View article titled, Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B<sub>12</sub> in Previously Treated Patients with Non-Small Cell Lung Cancer
Open the PDF for Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B<sub>12</sub> in Previously Treated Patients with Non-Small Cell Lung Cancer in another window
Journal Articles

Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib

Toshimi Takano, Yuichiro Ohe, Koji Tsuta, Tomoya Fukui, Hiromi Sakamoto, Teruhiko Yoshida, Ukihide Tateishi, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine, Hideo Kunitoh, Yoshihiro Matsuno, Koh Furuta, Tomohide Tamura
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5385–5390.
https://doi.org/10.1158/1078-0432.CCR-07-0627
Published: 17 September 2007
View article titled, Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib
Open the PDF for Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib in another window
Journal Articles

AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

Masayuki Takeda, Tokuzo Arao, Hideyuki Yokote, Teruo Komatsu, Kazuyoshi Yanagihara, Hiroki Sasaki, Yasuhide Yamada, Tomohide Tamura, Kazuya Fukuoka, Hiroshi Kimura, Nagahiro Saijo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3051–3057.
https://doi.org/10.1158/1078-0432.CCR-06-2743
Published: 15 May 2007
View article titled, AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor
Open the PDF for AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor in another window
Journal Articles

CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity

Anthe S. Zandvliet, Alwin D.R. Huitema, William Copalu, Yasuhide Yamada, Tomohide Tamura, Jos H. Beijnen, Jan H.M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 2970–2976.
https://doi.org/10.1158/1078-0432.CCR-06-2978
Published: 15 May 2007
View article titled, CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity
Open the PDF for CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity in another window
Journal Articles

Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

Hideharu Kimura, Kazuo Kasahara, Makoto Kawaishi, Hideo Kunitoh, Tomohide Tamura, Brian Holloway, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3915–3921.
https://doi.org/10.1158/1078-0432.CCR-05-2324
Published: 03 July 2006
View article titled, Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer
Open the PDF for Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer in another window
Journal Articles

Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903

Kaoru Kubota, Yutaka Nishiwaki, Takahiko Sugiura, Kazumasa Noda, Kiyoshi Mori, Masaaki Kawahara, Shunichi Negoro, Koshiro Watanabe, Fumio Imamura, Tomohide Tamura, Nagahiro Saijo
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5534–5538.
https://doi.org/10.1158/1078-0432.CCR-04-1771
Published: 01 August 2005
View article titled, Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903
Open the PDF for Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903 in another window